Discriminating Survival Outcomes in Patients with Glioblastoma Using a Simulation-Based, Patient-Specific Response Metric

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Neal, Maxwell Lewis ^a   Trister, Andrew D ^b   Cloke, Tyler ^a   Sodt, Rita ^a   Ahn, Sunyoung ^a   Baldock, Anne L ^a,c,d   Bridge, Carly A ^a,c,d   Lai, Albert ^e   Cloughesy, Timothy F ^e   Mrugala, Maciej M ^a   Rockhill, Jason K ^b   Rockne, Russell C ^a,c,d   Swanson, Kristin R ^a,c,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Brain Tumor Center   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; COMPUTER SIMULATION; GLIOBLASTOMA; HUMAN; KAPLAN MEIER METHOD; MATHEMATICAL MODEL; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; SCORING SYSTEM; SURVIVAL PREDICTION; THERAPY DELAY; TREATMENT RESPONSE; TUMOR GROWTH; VIRTUAL REALITY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COMPUTER SIMULATION; DISEASE PROGRESSION; GAMMA RAYS; GLIOBLASTOMA; HUMANS; INDIVIDUALIZED MEDICINE; LIKELIHOOD FUNCTIONS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84872770788     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051951     Document Type: Article

References (29)

1. Alvord EC Jr, (1995) Patterns of growth of gliomas. American Journal of Neuroradiology 16: 1013.
2. Alvord Jr EC, Shaw CM (1991) Neoplasms affecting the nervous system of the elderly. In: Duckett S, editor. The Pathology of the Aging Human Nervous System. Philadelphia: Lea and Fabiger. pp. 210-286.
3. Harpold HL, Alvord EC Jr, Swanson KR, (2007) The evolution of mathematical modeling of glioma proliferation and invasion. Journal of Neuropathology & Experimental Neurology 66: 1-9.
4. Wang CH, Rockhill JK, Mrugala M, Peacock DL, Lai A, et al. (2009) Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. Cancer Research 69: 9133-9140.
5. Macdonald DR, Cascino TL, Schold SC, Cairncross JG, (1990) Response criteria for phase II studies of supratentorial malignant glioma. Journal of Clinical Oncology 8: 1277.
6. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). European Journal of Cancer 45: 228-247.
7. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, et al. (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. Journal of Clinical Oncology 28: 1963.
8. Neal ML, Rockne R, Trister AD, Swanson KR, (2011) Predicting outcomes following therapy for glioblastoma using response metrics from patient-specific 3-dimensional tumor models. Neuro-Oncology 13: iii76-iii84.
9. Gu S, Chakraborty G, Champley K, Alessio A, Claridge J, et al. (2012) Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO PET images. Mathematical Medicine and Biology 29: 31-48.
10. Rockne R, Rockhill JK, Mrugala M, Spence AM, Kalet I, et al. (2010) Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach. Physics in Medicine and Biology 55: 3271-3285.
11. Swanson KR, Alvord EC Jr, (2002) Serial imaging observations and postmortem examination of an untreated glioblastoma: a traveling wave of glioma growth and invasion. Neuro-Oncology 4: 340.
12. Swanson KR, Rockne R, Rockhill J, Alvord EC Jr, (2007) Combining mathematical modeling with serial MR imaging to quantify and predict response to radiation therapy in individual glioma patients. Neuro-Oncology 9: 575-575.
13. Swanson KR, Harpold HL, Peacock DL, Rockne R, Pennington C, et al. (2008) Velocity of radial expansion of contrast-enhancing gliomas and the effectiveness of radiotherapy in individual patients: a proof of principle. Clinical Oncology 20: 301-308.
14. Szeto MD, Chakraborty G, Hadley J, Rockne R, Muzi M, et al. (2009) Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas. Cancer Research 69: 4502-4509.
15. Swanson KR (1999) Mathematical Modeling of the Growth and Control of Tumors: Ph.D. Dissertation. University of Washington.
16. Sodt R, Rockne R, Neal ML, Kalet I, Swanson K Quantifying the role of anisotropic invasion in human glioblastoma. Computational Surgery and Dual Training, Volume 2: Springer. In press.
17. Swanson KR, Rostomily RC, Alvord EC, (2008) A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle. British Journal of Cancer 98: 113-119.
18. Neal ML, Kerckhoffs RC, (2010) Current progress in patient-specific modeling. Briefings in Bioinformatics 11: 111-126.
19. Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, editor. Evaluation of Chemotherapeutic Agents: Columbia University Press. pp. 199-205.
20. Shaw EG, Seiferheld W, Scott C, Coughlin C, Leibel S, et al. (2003) Reexamining the radiation therapy oncology group (RTOG) recursive partitioning analysis (RPA) for glioblastoma multiforme (GBM) patients. International Journal of Radiation Oncology* Biology* Physics 57: S135-S136.
21. Swanson KR, Alvord EC Jr, Murray JD, (2000) A quantitative model for differential motility of gliomas in grey and white matter. Cell Proliferation 33: 317-329.
22. Swanson KR, Bridge C, Murray JD, Alvord EC, (2003) Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. Journal of the Neurological Sciences 216: 1-10.
23. Rockne R, Ellsworth CA Jr, Reed PJ, Kristin RS, (2008) Modeling the growth and invasion of gliomas, from simple to complex: the goldie locks paradigm. Biophysical Reviews and Letters 3: 111-123.
24. Friston KJ, Ashburner JT, Kiebel SJ, Nichols TE, Penny WD, editors (2007) Statistical Parametric Mapping: the Analysis of Functional Brain Images. London:Elsevier.
25. Mandonnet E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, et al. (2003) Continuous growth of mean tumor diameter in a subset of grade II gliomas. Annals of Neurology 53: 524-528.
26. Parsons DW, Jones S, Zhang X, Lin JCH, Leary RJ, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science's STKE 321: 1807.
27. Brandsma D, van den Bent MJ, (2009) Pseudoprogression and pseudoresponse in the treatment of gliomas. Current Opinion in Neurology 22: 633-638.
28. da Cruz LCH Jr, Rodriguez I, Domingues RC, Gasparetto EL, Sorensen AG, (2011) Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. American Journal of Neuroradiology 32: 1978-1985.
29. Stupp R, Dietrich PY, Kraljevic SO, Pica A, Maillard I, et al. (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. Journal of Clinical Oncology 20: 1375.